Clinical Trial Update: Detemir Energy Expenditure Study [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update for detemir assessing energy expenditure in individuals with type 2 diabetes mellitus and obesity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• detemir (insulin detemir)

Snippet

Sponsor: University of Surrey | Conditions: Type 2 Diabetes Mellitus, Obesity | Phase 4 | Status: COMPLETED